Clinical trial Recruiting at 2 sites Observational Ages 40 to 90

Evaluating visual field changes in glaucoma patients

Official title: An Observational Prospective Longitudinal Study for the Clinical Evaluation of Visual Field Change in Glaucoma. An Assessment of Different Models of Progression

Run by Centervue SpA · NCT05801471 · Data updated 2026-11-12

This study is trying to see how different ways of measuring vision changes can help track the progression of glaucoma in patients over three years.

Quick facts

Study typeObservational
Ages40 Years to 90 Years
SexAll
Enrollment200 (estimated)
SponsorCentervue SpA
Industry-sponsored
Locations2 sites (Milan, Milano and 1 other locations)
StatusRecruiting
StartedMay 6, 2022
Main results expectedNovember 6, 2028
Study endsNovember 6, 2028
Registry record updatedJanuary 2, 2026
Trial IDNCT05801471 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 40 to 90 with glaucomatous optic nerve head in both eyes and specific visual acuity and refraction criteria.

Probably not a fit

Patients with advanced glaucoma or other ocular conditions that could affect visual field assessments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to collect data over a 36-month period from patients with glaucoma to assess various methods for defining the progression of the disease. Participants will undergo repeated visits where their retinal functionality will be evaluated using the COMPASS fundus perimeter and the Humphrey Field Analyzer (HFA). Additionally, Optical Coherence Tomography (OCT) will be performed to gather clinical information about the retinal structure. The study focuses on understanding how different models can effectively track changes in visual fields associated with glaucoma.

Why it matters

Potential benefit: If successful, this study could lead to improved methods for monitoring glaucoma progression, enhancing patient management and treatment outcomes.

How similar studies have gone: While similar observational studies have been conducted, this specific approach to evaluating visual field progression in glaucoma is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Glaucomatous optic nerve head in both eyes;
* Age between 40 and 90 years;
* Best Corrected Visual Acuity ≤ 0.3 \[logMar\];
* Spherical refraction between -6D and +6D;
* Astigmatism between -2D and +2D.

Exclusion Criteria:

* Any ocular surgery, except for: uncomplicated cataract surgery and/or glaucoma surgery in both eyes performed within 6 months before enrollment;
* Any ocular pathology that can affect visual field other than glaucoma;
* Use of any drug that can interfere with the correct execution of perimetry or that would produce visual field loss;
* Inability to obtain reliable perimetric examinations;
* Patients with advanced glaucoma for whom, according to the clinician, a 24-2 grid is not advisable to correctly monitor the patient.

Where it's running

  • Clinica oculistica Ospedale San Paolo
    Milan, Milano, Italy
    Recruiting
  • Glaucoma Research Center, IRCCS Fondazione "G.B. Bietti"
    Roma, Roma, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.